PLIANT THERAPEUTICS, INC.
Last · —$0.8839-0.0841 (-8.69%)live · yahoo · 2h ago
Vol 445.5K ≈ 426.8K
MA10MA20MA50
Market cap$54.73M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Issuer
Legal namePLIANT THERAPEUTICS, INC.
HQUnited States (US)
ListingUS PLRX
ISINUS7291391057
SectorHealthcare
IndustryPharmaceuticals
SIC2834
CurrencyUSD
Entity registrysec:0001746473
CIK0001746473
Websitewww.pliantrx.com
Employees49
AddressPliant Therapeutics, Inc. 331 Oyster Point Boulevard 94080, South San Francisco +650 481 6770
Loading chart…
Upcoming earnings
THU.12NOV
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.37
Est. revenue
0
Press & signals
- GlobeNewswire
Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer
- GlobeNewswire
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
- GlobeNewswire
Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D., M.S.C.E. to Board of Directors